Nasdaq IPOs

Rani Therapeutics, which develops ingestible capsules for oral dosing of medication, announced terms for its IPO on Monday.The San Jose, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed ran

MaxCyte, which provides cell engineering devices and services, announced terms for its IPO on Monday.The Gaithersburg, MD-based company plans to raise $150 million by offering 12 million shares at a price range of $11.50 to $13.50. The company is currently listed on London's

The Better Being Co., which sells vitamins and supplements under the Solaray, KAL, and other brands, announced terms for its IPO on Monday. The Salt Lake City, UT-based company plans to raise $200 million by offering 12.5 million shares at a price range of $15 to $17. At the mid

Duolingo, an online language learning platform, raised the proposed deal size for its upcoming IPO on Monday.The Pittsburgh, PA-based company now plans to raise $498 million by offering 5.1 million shares (28% secondary) at a price range of $95 to $100. The company had previously

Omega Therapeutics, a preclinical biotech developing gene therapies for oncology and other diseases, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint

Immuneering, a preclinical biotech targeting signaling pathways to treat cancer and neurological diseases, announced terms for its IPO on Monday.The Cambridge, MA-based company plans to raise $105 million by offering 7 million shares at a price range of $14 to $16. At the midpoin

Candel Therapeutics, a Phase 3 biotech developing oncolytic viral immunotherapies for cancer, lowered the proposed deal size for its upcoming IPO on Monday.The Needham, MA-based company now plans to raise $72 million by offering 9 million shares at $8. The company had previously

Jupiter Acquisition, a blank check company formed by SPAC veteran James Hauslein targeting the consumer sector, lowered the proposed deal size for its upcoming IPO on Monday.The Hobe Sound, FL-based company now plans to raise $150 million by offering 15 million units at $10. The

Spartan Acquisition IV, a blank check company formed by Apollo Global Management targeting the energy transition space, lowered the proposed deal size for its upcoming IPO on Monday.The New York, NY-based company now plans to raise $300 million by offering 30 million units at $10

Spartan Acquisition IV, a blank check company formed by Apollo Global Management targeting the energy transition space, lowered the proposed deal size for its upcoming IPO on Monday.The New York, NY-based company now plans to raise $300 million by offering 30 million units at $10

After another week of record activity, the IPO market is expected to remain hot with 17 IPOs scheduled for the week ahead.   Long-awaited retail brokerage Robinhood Markets (HOOD) plans to raise $2.2 billion at a $36.8 billion market cap. The company offers a no-commission r

IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs submitted initial

After another week of record activity, the IPO market is expected to remain hot with 17 IPOs scheduled for the week ahead.   Long-awaited retail brokerage Robinhood Markets (HOOD) plans to raise $2.2 billion at a $36.8 billion market cap. The company offers a no-commission r

Muliang Viagoo Technology, a Chinese manufacturer and distributor of organic fertilizer and agricultural products, has launched its Nasdaq IPO. The Shanghai, China-based company plans to raise $40 million by offering 10 million shares at a price of $4 per share. At that pric

Cytek BioSciences, which provides cell analysis instruments for life science applications, raised $285 million by offering 16.7 million shares (30% secondary) at $17, within the range of $16 to $18. The offering contained 2.2 million more shares than anticipated. Cytek Bioscience

Falcon Peak Acquisition, a blank check company formed by TI Capital and Falcon Peak targeting tech-driven businesses, withdrew its plans for an initial public offering on Friday. It had filed to raise $250 million by offering 25 million units at $10.The New York, NY-based company

Belong Acquisition, a blank check company targeting high-growth tech and tech-enabled businesses, raised $150 million by offering 15 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.The company is led by&n

SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, raised $234 million by offering 13 million shares at $18, within the range of $17 to $19. SOPHiA GENETICS provides a cloud-based software-as-a-service (SaaS) platform capable of ana

Core & Main, a leading distributor of pipes and other industrial water infrastructure products, raised $698 million by offering 34.9 million shares at $20, the low end of the range of $20 to $23. Core & Main is a distributor of water infrastructure products that connects

Caribou Biosciences, a Phase 1 biotech developing gene edited cell therapies for multiple cancers, raised $304 million by offering 19 million shares at $16, the high end of the range of $14 to $16. The company offered 2 million more shares than anticipated. It originally planned